Drug Research

The growth of the domestic pharmaceutical industry and a reduction in reliance on imports might be facilitated by funding AI-based research and development and focusing on the key diseases that impact people in Africa, experts suggested at a recent...

Due to safety concerns, advisors to the European Medicines Agency on November 11th suggested restricting the use of a class of frequently prescribed anti-inflammatory medications. This recommendation follows a comparable but more stringent decision made by American authorities last...

Australia is the first country in the world to have awarded regulatory approval for faeces transplants. The healthy genetic material for this donation comes from the microbiomes of poop donors, who must meet a set of requirements. It has been...

ProductLife Group (PLG), a supplier of regulation and compliance solutions for the life sciences sector, has joined the Venture Centre of Excellence, EIT Health's regulatory hub. In order to help early-stage biotech, medtech, and digital health start-ups expedite their path...

The confidential agreement reached by the NHS and the manufacturer is expected to assist up to 1,600 women annually who have high-risk, triple-negative breast cancer. When combined with chemotherapy, pembrolizumab (trade name Keytruda®) reduces the likelihood of breast cancer...

In recent years, the high cost of gene therapies has emerged as a major barrier to the development of personalised medicines. Most notably, bluebird Bio was forced to pull its blood disorder medicine Zynteglo from the European market after...

As anticipated, Congress swiftly reauthorized four important user fee programmes as part of a bill that was essential to passing in order to continue funding the federal government for another two months. The October 1 deadline for approving a...